K. Kolquist

发表

Expression of TERT in early premalignant lesions and a subset of cells in normal tissues

Robert A. Weinberg, Daniel A. Haber, Lee K. Tan, 1998, Nature Genetics.

Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis

L. Shaffer, B. Ballif, M. Slovak, 2011, Molecular Cytogenetics.

Analytical validation of a melanoma diagnostic gene signature using formalin-fixed paraffin-embedded melanocytic lesions.

A. Gutin, M. B. Warf, R. Wenstrup, 2015, Biomarkers in medicine.

Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma

A. Gutin, J. Messina, C. Shea, 2015, Journal of cutaneous pathology.

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi

C. Cockerell, H. Kimbrell, J. McNiff, 2016, Cancer.

Fatal fat embolism syndrome in a child with undiagnosed hemoglobin S/beta+ thalassemia: a complication of acute parvovirus B19 infection.

D. Page, C. Vnencak-Jones, M. Denison, 1996, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour

W. Gerald, M. Ladanyi, D. Haber, 1997, Nature Genetics.

Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma.

A. Gutin, J. Reid, M. B. Warf, 2015, Biomarkers in medicine.

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome.

E. Snyder, M. Lovett, Amy Bernard, 1998, Proceedings of the National Academy of Sciences of the United States of America.

The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin

W. Gerald, D. Haber, J. Oliner, 1999, Cell.

The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists

C. Cockerell, J. Tschen, L. Clarke, 2016, Medicine.

A CLINICALLY VALIDATED GENE EXPRESSION SCORE IMPACTS DIAGNOSIS AND MANAGEMENT RECOMMENDATIONS OF MELANOCYTIC LESIONS BY DERMATOPATHOLOGISTS

L. Clarke, Brent A. Evans, Colleen Rock, 2015 .

Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes.

L. Shaffer, L. Campbell, B. Ballif, 2011, Cancer genetics.

Analytical Validation of a Cell Cycle Progression Signature Used as a Prognostic Marker in Prostate Cancer

J. Reid, H. Kimbrell, M. B. Warf, 2015 .

Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma

David R. Jones, W. Travis, J. Chaft, 2016, Oncotarget.

Development and validation of a gene expression signature to distinguish malignant melanoma from benign nevi.

A. Gutin, J. Messina, C. Shea, 2014 .

Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma.

A. Gutin, J. Reid, M. B. Warf, 2015, Biomarkers in medicine.